CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-17 | Shacham Sharon Chief Scientific Officer | Sale | −9,088 | $12.12 | $110K | 904,357 |
| 2022-02-17 | Shacham Sharon Chief Scientific Officer | Sale | −9,079 | $12.12 | $110K | 698,983 |
| 2022-02-17 | Kauffman Michael Director | Sale | −9,079 | $12.12 | $110K | 698,983 |
| 2022-02-17 | Kauffman Michael Director | Sale | −9,088 | $12.12 | $110K | 904,357 |
| 2022-02-07 | Shah Jatin EVP, Chief Medical Officer | Sale | −1,704 | $9.86 | $17K | 130,756 |
| 2022-02-07 | Frenkel Ran EVP, Chief Dev. Officer | Sale | −1,991 | $9.86 | $20K | 104,632 |
| 2022-02-07 | Mason Michael EVP, CFO & Treasurer | Sale | −3,947 | $9.86 | $39K | 53,308 |
Page 15 of 15 · 287 trades